230 related articles for article (PubMed ID: 10498874)
1. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death.
Knudsen KE; Weber E; Arden KC; Cavenee WK; Feramisco JR; Knudsen ES
Oncogene; 1999 Sep; 18(37):5239-45. PubMed ID: 10498874
[TBL] [Abstract][Full Text] [Related]
2. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice.
Truchet I; Jozan S; Guerrin M; Mazzolini L; Vidal S; Valette A
Exp Cell Res; 2000 Feb; 254(2):241-8. PubMed ID: 10640422
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function.
Barrientes S; Cooke C; Goodrich DW
Oncogene; 2000 Jan; 19(4):562-70. PubMed ID: 10698526
[TBL] [Abstract][Full Text] [Related]
4. Role of the retinoblastoma protein in cell cycle arrest mediated by a novel cell surface proliferation inhibitor.
Enebo DJ; Fattaey HK; Moos PJ; Johnson TC
J Cell Biochem; 1994 Jun; 55(2):200-8. PubMed ID: 8089195
[TBL] [Abstract][Full Text] [Related]
5. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
6. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
[TBL] [Abstract][Full Text] [Related]
8. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
9. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
10. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
[TBL] [Abstract][Full Text] [Related]
11. Equiguard suppresses androgen-dependent LNCaP prostate cancer cell proliferation by targeting cell cycle control via down regulation of the retinoblastoma protein Rb and induction of apoptosis via the release of cytochrome c.
Lu X; Hsieh TC; Wu JM
Int J Oncol; 2004 Dec; 25(6):1801-7. PubMed ID: 15547720
[TBL] [Abstract][Full Text] [Related]
12. Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system.
Lipinski MM; Macleod KF; Williams BO; Mullaney TL; Crowley D; Jacks T
EMBO J; 2001 Jul; 20(13):3402-13. PubMed ID: 11432828
[TBL] [Abstract][Full Text] [Related]
13. The proliferative and apoptotic activities of E2F1 in the mouse retina.
Lin SC; Skapek SX; Papermaster DS; Hankin M; Lee EY
Oncogene; 2001 Oct; 20(48):7073-84. PubMed ID: 11704831
[TBL] [Abstract][Full Text] [Related]
14. RB, the conductor that orchestrates life, death and differentiation.
Khidr L; Chen PL
Oncogene; 2006 Aug; 25(38):5210-9. PubMed ID: 16936739
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
16. Modeling the effect of the RB tumor suppressor on disease progression: dependence on oncogene network and cellular context.
Dean JL; McClendon AK; Stengel KR; Knudsen ES
Oncogene; 2010 Jan; 29(1):68-80. PubMed ID: 19802012
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
Pidgeon GP; Kandouz M; Meram A; Honn KV
Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
[TBL] [Abstract][Full Text] [Related]
18. Rb/E2F: a two-edged sword in the melanocytic system.
Halaban R
Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
[TBL] [Abstract][Full Text] [Related]
19. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals.
Chen PL; Riley DJ; Lee WH
Crit Rev Eukaryot Gene Expr; 1995; 5(1):79-95. PubMed ID: 7549181
[TBL] [Abstract][Full Text] [Related]
20. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
